Laboratory tests of a novel serotonin-binding compound have revealed an unexpected disconnect between receptor activation and ...
STUART, Fla.--(BUSINESS WIRE)--Cognigenics, a pioneering company in RNA-based therapeutics for neuropsychiatric conditions and neurocognitive disorders, announced the publication of its latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback